Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
INC Research and inVentiv Health announced the successful completion of their previously announced merger.
read more
Crown Bioscience announced the launch of pre-clinical models of IBD and RA to help inform decision making in pre-clinical drug development.
read more
Evotec AG and Aptuit have entered into a definitive agreement under which Evotec will acquire Aptuit for $ 300 million.
read more
Alcami announced an academic partnership with the University of North Carolina Wilmington (UNCW).
read more
Eurofins Scientific has closed the acquisition of GATC Biotech AG.
read more
TTP and New England Biolabs (NEB) announce that they have established a non-exclusive partnership to offer services to molecular diagnostic technology developers.
read more
Evotec announced an integrated drug discovery collaboration with STORM Therapeutics to develop new small molecule epigenetic drugs for oncology and other therapeutic areas.
read more
Eurofins Scientific has signed an agreement to acquire DiscoverX.
read more
Abarca has signed a value-based reimbursement contract with Biogen for select products in Biogen's leading multiple sclerosis portfolio.
read more
STA Pharmaceutical, a WuXi AppTec group company, has merged with WuXi AppTec’s Pharmaceutical Development Services division.
read more
ICON announced that it has acquired the Mapi Group.
read more
Baxter International announced the completion of the acquisition of Claris Injectables Limited, a global generic injectables pharmaceutical company.
read more
Dr. Reddy’s Laboratories and CHD Bioscience announced a global licensing agreement for the clinical development and commercialization of Dr. Reddy’s Phase III clinical trial candidate, DFA-02.
read more
Ginkgo Bioworks and Swissaustral announced a new partnership to design strains of microorganisms that will produce industrial enzymes at scale.
read more
Smithers Rapra announced the opening of its extractables and leachables lab located in Akron, Ohio at the Akron Global Business Accelerator.
read more